Date: 11.1.2023
Researchers in Spain have resurrected ancient CRISPR proteins from millions and even billions of years ago. Not only can they still edit human cells, but they’re more versatile than modern versions, paving the way for new and improved synthetic CRISPR gene-editing tools.
For the new study, researchers at CIC nanoGUNE in Spain set out to chart the evolution of CRISPR in microorganisms. To do so, they used a technique called ancestral sequence reconstruction, where specially designed algorithms are used to analyze and compare the genomes of living organisms, and determine what their common ancestors’ genomes would have looked like.
From this, the team identified and synthesized Cas enzymes that would likely have been used by ancient microorganisms, dating back between 37 million and 2.6 billion years ago. Tests in human cells confirmed that these ancestral enzymes were still functional in making gene edits.
Perhaps unsurprisingly, the ancient enzymes were far simpler than modern ones – a fingerprint of evolution in action. But intriguingly, that could allow them to be more versatile than their descendants, which have become more and more targeted to specific niches.
“Current systems are highly complex and are adapted to function within a bacterium,” said Raúl Pérez-Jiménez, lead researcher on the study. “When the system is used outside this environment, for example in human cells, it is rejected by the immune system and there are also certain molecular restrictions that limit its use. Oddly enough, in ancestral systems some of these restrictions disappear, which gives these systems greater versatility for new applications.”
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
This website is maintained by: CREOS CZ
© 2006 - 2024 South Bohemian Agency for Support to Innovative Enterprising (JAIP)
Interesting biotechnology content:
Cancer cells - Czech Scientists are Working to Find the Achilles‘ Heel of Cancer Cells
Biotechnologie - Czech Biotechnology information
Chimeric nanomicelles show promise as alternative treatment for solid tumors
Nanoparticles reprogram mouse immune systems to cope with allergens